Table of Contents
Overview
New York, NY – June 26, 2025 – Global Sequencing Consumables Market size is expected to be worth around US$ 65.7 Billion by 2034 from US$ 8.5 Billion in 2024, growing at a CAGR of 22.7% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 47.3% share with a revenue of US$ 4.0 Billion.
The global demand for sequencing consumables is witnessing consistent growth, driven by the rising adoption of genomic technologies across research, clinical, and pharmaceutical applications. Sequencing consumables include reagents, kits, flow cells, and sample preparation materials that are essential for the effective operation of sequencing instruments. These products are used recurrently, making them a significant revenue contributor to the overall sequencing market.
With the expansion of next-generation sequencing (NGS) technologies, the need for high-throughput, accurate, and cost-efficient consumables has intensified. Laboratories and healthcare institutions rely heavily on these consumables for applications in oncology, infectious disease diagnostics, genetic disorder screening, and agricultural genomics. Furthermore, the growing focus on personalized medicine and early disease detection is expected to drive demand for sequencing reagents in clinical settings.
According to the U.S. National Institutes of Health (NIH), large-scale genome research initiatives and biobank projects are accelerating procurement of sequencing consumables, particularly in North America and Europe. Additionally, government-supported genomic research in Asia-Pacific countries is expanding the user base for these products.
The continuous innovation in reagent chemistry and automation-compatible consumables is also enhancing workflow efficiency and reducing error rates. As a result, the sequencing consumables segment is projected to maintain dominance in the global sequencing product portfolio, contributing significantly to market expansion between 2025 and 2034.
Key Takeaways
- In 2024, the global sequencing consumables market was valued at US$ 8.5 billion and is projected to grow at a compound annual growth rate (CAGR) of 22.7%, reaching approximately US$ 65.7 billion by 2033.
- By product type, the market is categorized into kits, reagents, and accessories. Among these, kits dominated the segment in 2023, accounting for a leading market share of 57.6%, due to their widespread use in standardized sequencing workflows.
- Based on sequencing technology, the market is segmented into first-generation, second-generation, and third-generation platforms. Second-generation sequencing technologies held the highest share, capturing 55.4% of the market, owing to their accuracy, scalability, and broad application range.
- In terms of application, the market is divided into cancer diagnostics, reproductive health diagnostics, pharmacogenomics, infectious disease diagnostics, agrigenomics, and others. The cancer diagnostics segment emerged as the largest contributor, commanding a revenue share of 54.9%, reflecting the increasing use of sequencing in oncology.
- By end-user, the market includes hospitals & laboratories, academic research institutes, pharmaceutical & biotechnology companies, and others. In 2023, hospitals and laboratories led the market, accounting for 59.8% of total revenue, due to growing adoption of sequencing technologies in clinical diagnostics.
- Regionally, North America maintained market leadership, securing a 47.3% share in 2023, driven by strong research infrastructure, advanced healthcare systems, and high investment in genomic medicine.
Segmentation Analysis
- Product Analysis: In 2023, the kits segment dominated the market with a 57.6% share, driven by growing demand for high-throughput sequencing and efficient sample preparation. Kits offer integrated solutions that streamline workflows, reducing complexity in sequencing protocols. The ongoing development of specialized kits tailored to specific sequencing platforms is expected to boost their adoption, particularly in clinical diagnostics. The rise of personalized medicine further supports the segment’s growth in both research and healthcare applications.
- Technology Analysis: Second-generation sequencing technology, also known as next-generation sequencing (NGS), accounted for 55.4% of the market in 2023 due to its cost-effectiveness, scalability, and accuracy. This platform supports high-throughput applications such as whole-genome and transcriptome sequencing. Ongoing innovations and declining sequencing costs are expected to drive continued demand for 2nd generation consumables. Its reliability and established use across clinical, academic, and commercial sectors will likely maintain its dominant market position through the forecast period.
- Application Analysis: The cancer diagnostics segment held the largest share at 54.9%, fueled by the increasing role of genomic testing in cancer detection and treatment. Tumor profiling using sequencing technologies enables precision therapies based on individual genetic mutations. As personalized oncology expands, the reliance on sequencing consumables will grow. Rising cancer prevalence and broader use of targeted treatments are expected to significantly increase the adoption of sequencing in routine clinical oncology practices.
- End-Use Analysis: Hospitals and laboratories led the market in 2023, capturing a 59.8% revenue share due to expanding integration of sequencing into clinical diagnostics and research. These facilities are at the forefront of adopting genomic technologies for disease diagnosis, treatment planning, and biomarker discovery. The demand is further amplified by the shift toward precision medicine and declining sequencing costs. As healthcare institutions increasingly invest in genomic capabilities, the segment is expected to grow substantially.
Market Segments
Product
- Kits
- Target Enrichment
- RNA Library Preparation
- DNA Library Preparation
- Purification & Quality Control
- Library Quantification
- Others
- Reagents
- Sequencing
- Sample Prep
- Library Preparation & Amplification
- Accessories
- Plates
- Collection Tubes
- Others
Technology
- 3rd Generation
- 2nd Generation
- 1st Generation
Application
- Cancer Diagnostics
- Reproductive Health Diagnostics
- Pharmacogenomics
- Infectious Disease Diagnostics
- Agrigenomics
- Others
End-use
- Hospitals & Laboratories
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Regional Analysis
North America led the global sequencing consumables market in 2023, capturing a revenue share of 47.3%. This leadership is driven by robust investments in genomics research and growing clinical adoption of sequencing technologies. The U.S. National Institutes of Health (NIH) continues to fund large-scale genomic projects, including the Human Pangenome Project, contributing significantly to the demand for reagents and library preparation kits.
Additionally, sequencing has become integral to clinical diagnostics, particularly in oncology and infectious disease surveillance. The Centers for Disease Control and Prevention (CDC) processed over 270,000 SARS-CoV-2 genomes in 2022, illustrating the high throughput and material requirements. Academic and research institutions across the U.S. and Canada have also expanded their sequencing capacity, further fueling demand.
Asia Pacific is expected to register the highest compound annual growth rate (CAGR) during the forecast period. Government initiatives in countries such as China, India, South Korea, and Japan are advancing genomics research and precision medicine. China’s national genomics plan and India’s Genome India Project are anticipated to significantly boost demand for sequencing consumables.
Additionally, expanding healthcare infrastructure and increased awareness of personalized medicine across emerging economies in the region are expected to accelerate market growth, positioning Asia Pacific as a key future growth hub.
Emerging Trends
The cost of preparing sequencing libraries has fallen sharply, enabling high-throughput workflows. An NIH study demonstrated that 192 sequencing libraries can be produced in a single day at a cost of about US $15 per sample, down from over $50 just a few years ago. Hands-on time has been reduced by more than 75 percent, reagent costs by 55 percent, and consumable usage by 85 percent, making large-scale projects more feasible in both research and clinical settings.
Supply-chain planning and budgeting tools are being adopted to secure a reliable flow of reagents and consumables. The World Health Organization’s Genomics Costing Tool (GCT) supports countries in forecasting, ordering, and distributing quality-assured consumables across the genomics value chain. In a recent workshop in Namibia, over 50 laboratory and procurement staff were trained to use the GCT, ensuring timely supply for routine sequencing of up to 96 samples per run.
Use Cases
- Pathogen Genomic Surveillance: National programs have been scaled up to track viral evolution. By May 6, 2021, the U.S. CDC had processed 177,044 SARS-CoV-2 genome sequences through its National SARS-CoV-2 Strain Surveillance program, with data updated every two weeks to guide vaccine strain selection. The median time from specimen collection to sequence deposition was 25 days (IQR 22–28), enabling timely public health responses.
- Metagenomic Sequencing from Rapid Tests: An innovative use case repurposed residual swabs from negative SARS-CoV-2 rapid antigen tests for broad virus detection. In a study of 53 residual samples, 18 were found to contain other respiratory pathogens, and full genome sequences were generated for each positive sample. This approach streamlines consumable use by leveraging existing materials and supports surveillance of multiple viruses with minimal additional input.
Conclusion
The global sequencing consumables market is poised for substantial growth, driven by rapid advancements in genomic technologies, increased clinical adoption, and government-supported research initiatives. With a projected CAGR of 22.7%, the market is expected to reach US$ 65.7 billion by 2034. Key drivers include the growing role of sequencing in cancer diagnostics, pathogen surveillance, and personalized medicine.
North America currently leads the market, while Asia Pacific is anticipated to witness the fastest growth. Ongoing innovations, declining costs, and improved workflow efficiencies are expected to further accelerate adoption, solidifying sequencing consumables as a critical component in modern biomedical science.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
